Protein ISGylation modulates the JAK-STAT signaling pathway (original) (raw)
- Oxana A. Malakhova1,3,
- Ming Yan1,3,
- Michael P. Malakhov1,
- Youzhong Yuan1,
- Kenneth J. Ritchie1,
- Keun Il Kim1,
- Luke F. Peterson1,
- Ke Shuai2, and
- Dong-Er Zhang1,4
- 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA;2Division of Hematology/Oncology, University of California at Los Angeles, School of Medicine, Los Angeles, California 90095, USA
Abstract
ISG15 is one of the most strongly induced genes upon viral infection, type I interferon (IFN) stimulation, and lipopolysaccharide (LPS) stimulation. Here we report that mice lacking UBP43, a protease that removes ISG15 from ISGylated proteins, are hypersensitive to type I IFN. Most importantly, in UBP43-deficient cells, IFN-β induces a prolonged Stat1 tyrosine phosphorylation, DNA binding, and IFN-mediated gene activation. Furthermore, restoration of ISG15 conjugation in protein ISGylation-defective K562 cells increases IFN-stimulated promoter activity. These findings identify UBP43 as a novel negative regulator of IFN signaling and suggest the involvement of protein ISGylation in the regulation of the JAK-STAT pathway.
Footnotes
↵3 These authors contributed equally to this work.
↵4 Corresponding author.
E-MAIL dzhang{at}scripps.edu; FAX (858) 784-9593.
Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1056303.
- Received November 4, 2002.
- Accepted December 24, 2002.
Cold Spring Harbor Laboratory Press